Aptamer Inhibits Degradation of Platelet Proteolytically Activatable Receptor, PAR-1, by Thrombin

By Boncler M.A.   Koziolkiewicz M.   Watala C.  

Thrombosis Research, Vol. 104, Iss. 3, 2001-11 ,pp. : 215-222

Elsevier

Access to resources Recommend Favorite

Non-Peptidic Small-Molecule Antagonists of the Human Platelet Thrombin Receptor PAR-1

By  

Current Medicinal Chemistry - Cardiovascular & Hematological Agents, Vol. 1, Iss. 1, 2003-03 ,pp. : 47-59

Bentham Science Publishers

Access to resources Recommend Favorite

Stability validation of paraformaldehyde-fixed samples for the assessment of the platelet PECAM-1, P-selectin, and PAR-1 thrombin receptor by flow cytometry

By Atar Oliver   Eisert Christian   Pokov Ilya   Serebruany Victor  

Journal of Thrombosis and Thrombolysis, Vol. 30, Iss. 1, 2010-07 ,pp. : 79-83

Springer Publishing Company

Access to resources Recommend Favorite

Regulation of platelet biology by platelet endothelial cell adhesion molecule-1

By Jones Chris I.   Moraes Leonardo A.   Gibbins Jonathan M.  

Platelets, Vol. 23, Iss. 5, 2012-08 ,pp. : 331-335

Informa Healthcare

Access to resources Recommend Favorite

Species differences in platelet responses to thrombin and SFLLRN. Receptor-mediated calcium mobilization and aggregation, and regulation by protein kinases

By Derian C.K.   Santulli R.J.   Tomko K.A.   Haertlein B.J.   Andrade-Gordon P.  

Thrombosis Research, Vol. 78, Iss. 6, 1995-06 ,pp. : 505-519

Elsevier

Access to resources Recommend Favorite